These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 27571750)

  • 1. Crystal structure of Clostridium difficile toxin A.
    Chumbler NM; Rutherford SA; Zhang Z; Farrow MA; Lisher JP; Farquhar E; Giedroc DP; Spiller BW; Melnyk RA; Lacy DB
    Nat Microbiol; 2016 Jan; 1():15002. PubMed ID: 27571750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of
    Chumbler NM; Rutherford SA; Zhang Z; Farrow MA; Lisher JP; Farquhar E; Giedroc DP; Spiller BW; Melnyk RA; Lacy DB
    Nat Microbiol; 2016; 1():. PubMed ID: 27512603
    [No Abstract]   [Full Text] [Related]  

  • 3. A neutralizing antibody that blocks delivery of the enzymatic cargo of
    Kroh HK; Chandrasekaran R; Zhang Z; Rosenthal K; Woods R; Jin X; Nyborg AC; Rainey GJ; Warrener P; Melnyk RA; Spiller BW; Lacy DB
    J Biol Chem; 2018 Jan; 293(3):941-952. PubMed ID: 29180448
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of a neutralizing antibody helps identify structural features critical for binding of
    Kroh HK; Chandrasekaran R; Rosenthal K; Woods R; Jin X; Ohi MD; Nyborg AC; Rainey GJ; Warrener P; Spiller BW; Lacy DB
    J Biol Chem; 2017 Sep; 292(35):14401-14412. PubMed ID: 28705932
    [No Abstract]   [Full Text] [Related]  

  • 5. Structure-function analysis of inositol hexakisphosphate-induced autoprocessing in Clostridium difficile toxin A.
    Pruitt RN; Chagot B; Cover M; Chazin WJ; Spiller B; Lacy DB
    J Biol Chem; 2009 Aug; 284(33):21934-21940. PubMed ID: 19553670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autocatalytic processing of Clostridium difficile toxin B. Binding of inositol hexakisphosphate.
    Egerer M; Giesemann T; Herrmann C; Aktories K
    J Biol Chem; 2009 Feb; 284(6):3389-95. PubMed ID: 19047051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridium difficile Toxin Biology.
    Aktories K; Schwan C; Jank T
    Annu Rev Microbiol; 2017 Sep; 71():281-307. PubMed ID: 28657883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The structure of Clostridium difficile toxin A glucosyltransferase domain bound to Mn2+ and UDP provides insights into glucosyltransferase activity and product release.
    D'Urzo N; Malito E; Biancucci M; Bottomley MJ; Maione D; Scarselli M; Martinelli M
    FEBS J; 2012 Sep; 279(17):3085-97. PubMed ID: 22747490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural determinants of Clostridium difficile toxin A glucosyltransferase activity.
    Pruitt RN; Chumbler NM; Rutherford SA; Farrow MA; Friedman DB; Spiller B; Lacy DB
    J Biol Chem; 2012 Mar; 287(11):8013-20. PubMed ID: 22267739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rho-glucosylating Clostridium difficile toxins A and B: new insights into structure and function.
    Jank T; Giesemann T; Aktories K
    Glycobiology; 2007 Apr; 17(4):15R-22R. PubMed ID: 17237138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward a structural understanding of Clostridium difficile toxins A and B.
    Pruitt RN; Lacy DB
    Front Cell Infect Microbiol; 2012; 2():28. PubMed ID: 22919620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of receptor-binding C-terminal repeats from Clostridium difficile toxin A.
    Ho JG; Greco A; Rupnik M; Ng KK
    Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18373-8. PubMed ID: 16344467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural organization of the functional domains of Clostridium difficile toxins A and B.
    Pruitt RN; Chambers MG; Ng KK; Ohi MD; Lacy DB
    Proc Natl Acad Sci U S A; 2010 Jul; 107(30):13467-72. PubMed ID: 20624955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoproteolytic cleavage mediates cytotoxicity of Clostridium difficile toxin A.
    Kreimeyer I; Euler F; Marckscheffel A; Tatge H; Pich A; Olling A; Schwarz J; Just I; Gerhard R
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Mar; 383(3):253-62. PubMed ID: 21046073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridium difficile toxin glucosyltransferase domains in complex with a non-hydrolyzable UDP-glucose analogue.
    Alvin JW; Lacy DB
    J Struct Biol; 2017 Jun; 198(3):203-209. PubMed ID: 28433497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical and Immunological Characterization of Truncated Fragments of the Receptor-Binding Domains of C. difficile Toxin A.
    Huang JH; Shen ZQ; Lien SP; Hsiao KN; Leng CH; Chen CC; Siu LK; Chong PC
    PLoS One; 2015; 10(8):e0135045. PubMed ID: 26271033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of an Essential Region for Translocation of Clostridium difficile Toxin B.
    Chen S; Wang H; Gu H; Sun C; Li S; Feng H; Wang J
    Toxins (Basel); 2016 Aug; 8(8):. PubMed ID: 27537911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Processing of Clostridium difficile toxins.
    Giesemann T; Egerer M; Jank T; Aktories K
    J Med Microbiol; 2008 Jun; 57(Pt 6):690-696. PubMed ID: 18480324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Masking autoprocessing of Clostridium difficile toxin A by the C-terminus combined repetitive oligo peptides.
    Zhang Y; Hamza T; Gao S; Feng H
    Biochem Biophys Res Commun; 2015 Apr; 459(2):259-263. PubMed ID: 25725153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbohydrate recognition by Clostridium difficile toxin A.
    Greco A; Ho JG; Lin SJ; Palcic MM; Rupnik M; Ng KK
    Nat Struct Mol Biol; 2006 May; 13(5):460-1. PubMed ID: 16622409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.